How Asia is Addressing Mental Health Issues?
BioSpectrum Asia|October 2024
Nearly one billion people globally live with mental health conditions, and about 260 million of them reside in the World Health Organization WHO) South-East Asia Region. Governments across Asia are ramping up efforts to combat the rising mental health crisis. As October 10 will be observed as World Mental Health Day, we take a look at the region's focus on policy reforms to address the growing burden of mental healthcare across Asia.
- Ayesha Siddiqui
How Asia is Addressing Mental Health Issues?

Mental health issues are well-documented, affecting nearly one billion people worldwide, with approximately 260 million residing in the WHO South-East Asia Region. Insufficient investment in mental health services and the healthcare workforce has led to significant treatment gaps in the region, a situation further worsened by the COVID-19 pandemic. Global estimates indicate the WHO South-East Asia Region accounts for around 27 per cent of all cases of depression and 23 per cent of all cases of anxiety.

Despite its inclusion in the Sustainable Development Goals (SDGs), only 2 per cent of total government health expenditure and 1 per cent of global development assistance for health are dedicated to mental health, according to the WHO’s Mental Health Atlas 2020.

Mental illness presents a significant health and socioeconomic burden, accounting for over 20 per cent of total Years Lived with Disability (YLDs) and 9.3 per cent of Disability-Adjusted Life Years (DALYs) in the Asia-Pacific region. As per a report by The Royal Australian and New Zealand College of Psychiatrists (2016), even advanced economies like Australia and New Zealand face GDP deficits of 3.5 per cent and 5 per cent, respectively, linked to mental illness. Furthermore, it is estimated that by 2030, mental illness will result in a loss of $11 trillion in economic growth for India and China alone, according to a report ‘Provision for Supporting People with Mental Illness: A Comparison of 15 Asia-Pacific Countries,’ prepared by The Economist Intelligence Unit (EIU) and sponsored by Janssen Asia Pacific.

To address these growing concerns, policymakers and health systems across the region are taking a note. Various countries have developed national strategic plans and made investments to strengthen mental healthcare.

この蚘事は BioSpectrum Asia の October 2024 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

この蚘事は BioSpectrum Asia の October 2024 版に掲茉されおいたす。

7 日間の Magzter GOLD 無料トラむアルを開始しお、䜕千もの厳遞されたプレミアム ストヌリヌ、9,000 以䞊の雑誌や新聞にアクセスしおください。

BIOSPECTRUM ASIAのその他の蚘事すべお衚瀺
How To Control Indian Diabetes Growth
BioSpectrum Asia

How To Control Indian Diabetes Growth

World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.

time-read
4 分  |
December 2024
HIV Prevention Remains Elusive
BioSpectrum Asia

HIV Prevention Remains Elusive

On December 1, the world gathers every year to commemorate World AIDS Day, which serves as an important reminder that we must remain steadfast in our commitment to prevent new HIV (Human Immunodeficiency Virus) infections and provide essential services to all people living with HIV globally. In 2024, the 37th World AIDS Day opens with the theme, \"Collective Action: Sustain and Accelerate HIV Progress.\"

time-read
2 分  |
December 2024
Karnataka launches India's first GCC policy
BioSpectrum Asia

Karnataka launches India's first GCC policy

Bengaluru Tech Summit 2024

time-read
8 分  |
December 2024
Innovations in Urological Imaging: Transforming Patient Care in India
BioSpectrum Asia

Innovations in Urological Imaging: Transforming Patient Care in India

Despite advancements in urological imaging, challenges persist in India, particularly regarding cost and accessibility. Government initiatives and public-private partnerships should expand access to imaging facilities. Continued research investment is crucial for developing cost-effective solutions.

time-read
5 分  |
December 2024
How strategic angel investment is driving global expansion in medtech and diagnostics
BioSpectrum Asia

How strategic angel investment is driving global expansion in medtech and diagnostics

India has firmly established itself as a key player in the global medtech and diagnostics sectors. With a burgeoning healthcare ecosystem and a growing focus on innovation, the country offers a fertile ground for startups looking to scale their solutions both domestically and internationally. Central to this growth is the role of strategic angel investment, which not only provides financial backing but also offers critical mentorship and strategic direction to help these companies expand their reach.

time-read
4 分  |
December 2024
What's dampening the GLOBAL AMR BATTLE?
BioSpectrum Asia

What's dampening the GLOBAL AMR BATTLE?

Although there have been significant national and worldwide efforts to provide financial incentives for antibiotic research and development, it is still unclear how best to fortify the existing programmes to further spur antibiotic innovation. The incentive programmes in place now are a crucial first step in enhancing the economic viability of antibiotic development. However, it seems like there isn't enough global coordination among all the programmes, which could lead to duplication of effort, funding gaps in the value chain, and the failure to include crucial AMR objectives. Let's dig deeper.

time-read
9 分  |
December 2024
Indian Lifesciences Industry Going Ahead in its Innovation Journey While Navigating Challenges
BioSpectrum Asia

Indian Lifesciences Industry Going Ahead in its Innovation Journey While Navigating Challenges

While India is a hub for biosimilar manufacturing and continues to build its capabilities to manufacture these complex therapeutics, Indian biopharma companies are building R&D capabilities and establishing public-private collaborations and Centre of Excellences (CoEs) to develop innovative biologics and advanced therapeutic modalities like cell and gene therapy (CGT) and mRNA vaccines and therapies, biopharma sector remained robust in 2023, accounting for $53.8 billion (35 per cent of the BioEconomy). The growth was primarily driven by advances in biotechnology, personalised medicine innovations, and an expanding market for biosimilars in 2024.

time-read
5 分  |
December 2024
BioPharma's Transformative & Strategic OUTLOOK 2025
BioSpectrum Asia

BioPharma's Transformative & Strategic OUTLOOK 2025

The Indian biopharma industry witnessed notable transformative developments and announcements, marked by innovation, regulatory advancements, and market expansion this year. From achieving global recognition in biosimilars to advancing biomanufacturing capabilities and precision therapeutics, the sector has solidified its role as a key player in the global pharmaceutical landscape. This progress underscores India's strategic focus on leveraging its robust infrastructure, skilled talent pool, and government support to meet the evolving demands of the healthcare industry.

time-read
10+ 分  |
December 2024
Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time
BioSpectrum Asia

Promega unveils GloMax Galaxy Bioluminescence Imager for illuminating protein dynamics in real time

US-based Promega Corporation, a life-sciences research partner dedicated to providing intuitive tools that empower scientists to innovate, has unveiled the new GloMax Galaxy Bioluminescence Imager.

time-read
1 min  |
BioSpectrum Asia Nov 2024
Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers
BioSpectrum Asia

Singleron and Bioscreen to enhance access to single cell multi-omics solutions for Indian researchers

Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor of advanced life science products in India.

time-read
1 min  |
BioSpectrum Asia Nov 2024